NCLAT dismisses Religare’s appeal against CCI nod

May 6, 2024

NCLAT rejected REL’s appeal regarding Burman’s share acquisition. CCI ensures fair competition. Justice Khanna and Mehrotra maintained status quo. Fraud allegations, ESOP issuance, remuneration without approval are under scrutiny.

More To Explore

Investors not inclined to ‘sell India buy China’ but to ‘sell India buy USA’: Samir Arora

Samir Arora cautioned investors not to get overly excited by CLSA’s increased allocation to India. He believes that investors were shifting to the US, not

November 16, 2024

These 15 smallcap stocks fell 15-25% in a week

Over the past week, the benchmark index fell by about 2.4%, while the BSE Smallcap index plunged 4.6%. Amid significant smallcap losses, ETMarkets identified the

November 16, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003